Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gian Marco Podda

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Internal and Emergency Medicine|February 24, 2010
State of the art of new P2Y12 antagonistsMarco Cattaneo, Gian Marco Podda
Thrombosis and Haemostasis|March 31, 2017
High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMIGian Marco Podda, Marco Cattaneo
Internal and Emergency Medicine|November 6, 2016
Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhageSimone Birocchi, Gian Marco Podda,
Internal and Emergency Medicine|May 5, 2011
Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosisLaura Ferrari, Gian Marco Podda
Internal and Emergency Medicine|November 1, 2014
Platelet transfusion strategy for hematologic cancersGian Marco Podda, Silvia Ricci
Internal and Emergency Medicine|December 15, 2015
Is perioperative bridging anticoagulation useful in patients with atrial fibrillation?Elisa Maria Fiorelli, Gian Marco Podda,
European Journal of Internal Medicine|December 20, 2023
Non-adherence to chronic treatments: A commitment for Internal Medicine specialistsBianca Clerici, Simone Birocchi, Gian Marco Podda
The New England Journal of Medicine|June 9, 2009
Dronedarone in atrial fibrillationMariateresa Pugliano, Giorgio Costantino, Gian Marco Podda, et al.
Archives of Internal Medicine|January 25, 2012
Do procalcitonin algorithms modify mortality?Laura Ferrari, Francesco Casella, Gian Marco Podda, et al.
Internal and Emergency Medicine|August 6, 2009
Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?Federico Lussana, Gian Marco Podda, Marco Cattaneo
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Internal and Emergency Medicine|February 24, 2010
State of the art of new P2Y12 antagonistsMarco Cattaneo, Gian Marco Podda
Thrombosis and Haemostasis|March 31, 2017
High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMIGian Marco Podda, Marco Cattaneo
Internal and Emergency Medicine|November 6, 2016
Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhageSimone Birocchi, Gian Marco Podda,
Internal and Emergency Medicine|May 5, 2011
Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosisLaura Ferrari, Gian Marco Podda
Internal and Emergency Medicine|November 1, 2014
Platelet transfusion strategy for hematologic cancersGian Marco Podda, Silvia Ricci
Internal and Emergency Medicine|December 15, 2015
Is perioperative bridging anticoagulation useful in patients with atrial fibrillation?Elisa Maria Fiorelli, Gian Marco Podda,
European Journal of Internal Medicine|December 20, 2023
Non-adherence to chronic treatments: A commitment for Internal Medicine specialistsBianca Clerici, Simone Birocchi, Gian Marco Podda
The New England Journal of Medicine|June 9, 2009
Dronedarone in atrial fibrillationMariateresa Pugliano, Giorgio Costantino, Gian Marco Podda, et al.
Archives of Internal Medicine|January 25, 2012
Do procalcitonin algorithms modify mortality?Laura Ferrari, Francesco Casella, Gian Marco Podda, et al.
Internal and Emergency Medicine|August 6, 2009
Can plasma levels of N-terminal pro-brain natriuretic peptide be useful in predicting the risk of developing chronic pulmonary hypertension in patients with pulmonary embolism?Federico Lussana, Gian Marco Podda, Marco Cattaneo
Pageof 9